From New Molecular Insights to New Treatment Options in Endometrial Cancer
Endometrial cancer remains the most common gynecological cancer in Europe and the US, with excellent survival rates in patients with early-stage disease.^1^ However, the prognosis of advanced/metastatic endometrial cancer is dismal. There is a considerable need to refine treatment options in the adj...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2022-03-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000//hbT.OH.2022.11.063 |